Work

Supplementary Figure S5 from The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs

Year: 2024

Type: supplementary-materials

Abstract: This figure shows profiling of cell viability after M1774 treatment in DMS114 and DU145 cells, and a correlation plot between topotecan and SLFN11 expression.

DOI: 10.1158/1535-7163.26190702.v1

Authors: Ukhyun Jo, Yasuhiro Arakawa, Astrid Zimmermann, Daiki Taniyama, Makito Mizunuma, Lisa M. Jenkins, Tapan K. Maity, Suresh Kumar, Frank T. Zenke, Naoko Takebe, Yves Pommier

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4400358566

Cites:

Cited by:

Related to: 10